Laurus Bio - About the company
Laurus Bio is an unfunded company based in Bengaluru (India), founded in 2005 by Subramani Ramachandrappa. It operates as a CDMO focused on providing services for stem cell, biological drugs, and regenerative medicines. Laurus Bio has not raised any funding yet, with a current valuation of $*****. The company has 337 active competitors, including 22 funded and 98 that have exited. Its top competitors include companies like Anthem Biosciences, Patheon and Aragen.
Company Details
An integrated research-driven biomanufacturing organization specializing in precision fermentation. It engineers microbes to produce animal-free proteins and growth factors for biopharma, food, and other markets. This organization offers CDMO services, encompassing clone development, strain engineering, and large-scale manufacturing. Their expertise extends to precision fermentation and recombinant technology, creating safe, virus-free, and sustainable products. The organization's manufacturing facility is cGMP-certified, adhering to high quality and regulatory standards. They serve various industries including cultured meat, cell culture media, and vaccine production.
- Website
- laurus.bio
- Registered Address
- PLOT NO. 204 AND 237, BOMMASANDRA-JIGANI LINK ROAD KIADB INDUSTRIAL AREA, JIGANI HOBLI, ANE, KAL TALUK, Bangalore, BANGALORE, Karnataka, India, 560105
Key Metrics
Founded Year
2005
Location
Bengaluru, India
Stage
Unfunded
Total Funding
Post Money Valuation
$***** as on Dec 20, 2024
Investors
Ranked
57th among 337 active competitors
Annual Revenue
₹1,000+ Cr as on Mar 31, 2026
Employee Count
546 as on Aug 31, 2026
Similar Companies
Legal entities associated with Laurus Bio
Laurus Bio is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
LAURUS LABS LIMITED CIN: L24239AP2005PLC047518 , India, Active | Sep 19, 2005 | ₹1,000+ Cr (As on Mar 31, 2026) | 7191 (As on Apr 01, 2026) | |
LAURUS BIO PRIVATE LIMITED CIN: U02423KA2005PTC036770 , India, Active | Jul 14, 2005 | ₹100 - ₹500 Cr (As on Mar 31, 2026) | 392 (As on Dec 31, 2024) |
Sign up to download Laurus Bio's company profile
Laurus Bio's funding and investors
Laurus Bio has raised a total funding of $18.9M. Laurus Bio has 2 institutional investors.
View details of Laurus Bio's funding rounds and investors
Laurus Bio's founders and board of directors
Founder? Claim ProfileThe founders of Laurus Bio is Subramani Ramachandrappa. Rajesh Krishnamurthy is the CEO of Laurus Bio.
Here are the details of Laurus Bio's key team members:
- Subramani Ramachandrappa: Former Founder of Laurus Bio.
- Rajesh Krishnamurthy: CEO of Laurus Bio. Contact Info: 1 email address and 1 phone number
View details of Laurus Bio's Founder profiles and Board Members
Laurus Bio's employee count trend
Laurus Bio has 546 employees as of Aug 26. Here is Laurus Bio's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Laurus Bio's Competitors and alternates
Top competitors of Laurus Bio include Anthem Biosciences, Patheon and Aragen. Here is the list of Top 10 competitors of Laurus Bio, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Anthem Biosciences 2006, Bengaluru (India), Public | Developer of integrated contract research development and manufacturing services | $35.7M | 77/100 | |
2nd | Patheon 1974, Durham (United States), Acquired | Global CDMO providing integrated drug development, clinical trials, and manufacturing services | $141M | 74/100 | |
3rd | Provider of drug discovery, clinical development, manufacturing, and other services for small molecules | $161M | 69/100 | ||
4th | KBI Biopharma 1996, Durham (United States), Acquired | Provider of protein formulation, process & cell line development, and cGMP services | $21M | 68/100 | |
5th | Provider of contract research and manufacturing services for both small molecules and biologics | $85.9M | 66/100 | ||
6th | Abzena 2001, Cambridge (United Kingdom), Acquired | Provider of antibody discovery, cell line development, and bio analytics services | $67.1M | 66/100 | |
7th | Abingdon Health 2008, York (United Kingdom), Public | Developer of immunoassays for diagnostic purposes | $24.1M | 64/100 | |
8th | Panacea Biotec 1984, Ambala (India), Public | Developer of biosimilars, vaccines and natural products | - | 62/100 | |
9th | Grand River Aseptic Manufacturing 2010, Grand Rapids (United States), Acquired | Aseptic manufacturing CDMO providing fill-finish services for sterile injectables | $16.9M | 59/100 | |
10th | Contract development and manufacturing organization for biologics | - | 58/100 | ||
57th | Laurus Bio 2005, Bengaluru (India), Unfunded | CDMO focused on providing services for stem cell, biological drugs, and regenerative medicines | $18.9M | 42/100 |
Looking for more details on Laurus Bio's competitors? Click here to see the top ones
Laurus Bio's Investments and acquisitions
Laurus Bio has made no investments or acquisitions yet.
Reports related to Laurus Bio
Here is the latest report on Laurus Bio's sector:
News related to Laurus Bio
•
Funding in pharma surges in December 2024, reached $69.8 mnExpress Pharma•Jan 06, 2025•3Gen Consulting, Laurus Bio, Orange Health, ASVF and 1 other
•
•
Pharma company Laurus Labs acquires 87.59% stake in Laurus Bio PrivateBusiness Standard•Nov 21, 2023•Laurus Labs, Laurus Bio
Are you a Founder ?
FAQs about Laurus Bio
Explore our recently published companies
- TimeXchange - South Africa based, 2025 founded, Unfunded company
- TriSixty Security - Marlborough based, Unfunded company
- Triene.com - 2019 founded, Unfunded company
- Topboxanalytics.com - Unfunded company
- TomorrowNow - Houston based, 1999 founded, Unfunded company
- Traqpath - 2014 founded, Unfunded company
